RxDoctor Payments Data

Gregory Lervick, MD

Orthopaedic Surgery · Edina, MNNPI 1881701829

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $5,172 of the $7,852 with a category attached, or 65.9%. Medacta USA, Inc. accounts for 78.3% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $4,591 and has fallen 56.9% since, to $1,977 in 2025.

$7,852in general payments, 2019–2025

Across 40 payments — averaging $196.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medacta USA, Inc.$6K
  • Gemini Medical LLC$488
  • Exactech, Inc.$393
  • Anika Therapeutics, Inc.$221
  • Smith+Nephew$170
  • Johnson & Johnson$147
  • plus $288 from 4 others
$200,512in ownership & investment interests, 2019–2025

Across 7 payments — averaging $28,645 each. An ownership or investment interest held by the physician or an immediate family member.

  • Responsive Arthroscopy Inc$201K

What the payments were for

  • Travel & lodging$5,17266%
  • Food & beverage$2,19328%
  • Education$4886%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,852 in reported general payments places this provider in the 60th percentile of 533 orthopaedic surgery providers in Minnesota.

See all orthopaedic surgery providers in Minnesota

Medicare billing

Part B allowed, 2024
$88,188
Medicare patients
205
Services billed
760

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin65$223

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Edina

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →